Genentech announces data at EHA 2021 reinforcing efficacy of Venclexta combinations in chronic lymphocytic leukemia and acute myeloid leukemia
Genentech, a member of the Roche Group announced the latest data from three pivotal Phase III studies of Venclexta (venetoclax) – CLL14, MURANO and VIALE-A – to be… read more.
